000 01934 a2200469 4500
005 20250516072939.0
264 0 _c20120508
008 201205s 0 0 eng d
022 _a1464-5157
024 7 _a10.3109/02656736.2011.626834
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTschoep-Lechner, Katharina
245 0 0 _aModified vaccinia virus Ankara delivers a robust surrogate marker for immune monitoring to sarcoma cells even if cells are being exposed to chemotherapy and heat treatment.
_h[electronic resource]
260 _bInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
_c2012
300 _a33-42 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntigen Presentation
650 0 4 _aAntineoplastic Agents, Alkylating
_xpharmacology
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Survival
650 0 4 _aGreen Fluorescent Proteins
_ximmunology
650 0 4 _aHot Temperature
650 0 4 _aHumans
650 0 4 _aIfosfamide
_xpharmacology
650 0 4 _aInterferon-gamma
_ximmunology
650 0 4 _aMonophenol Monooxygenase
_xgenetics
650 0 4 _aSarcoma
_ximmunology
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTransduction, Genetic
650 0 4 _aTumor Cells, Cultured
650 0 4 _aVaccinia
_ximmunology
650 0 4 _aVaccinia virus
_xgenetics
700 1 _aDrexler, Ingo
700 1 _aHammer, Doreen
700 1 _aNeumann, Daniel
700 1 _aPohla, Heike
700 1 _aSutter, Gerd
700 1 _aNoessner, Elfriede
700 1 _aIssels, Rolf-Dieter
773 0 _tInternational journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group
_gvol. 28
_gno. 1
_gp. 33-42
856 4 0 _uhttps://doi.org/10.3109/02656736.2011.626834
_zAvailable from publisher's website
999 _c21452436
_d21452436